Search

Displaying results 8881 - 8890 of 10000 in total
  1. Drug

    Flovagatran

    go.drugbank.com/drugs/DB05714
    Experimental

  2. Drug

    LCP-AtorFen

    go.drugbank.com/drugs/DB05769
    Investigational

    LCP-AtorFen is a fixed-dose combination therapy for the treatment of high cholesterol levels combining atorvastatin (the active ingredient of Lipitor®) and the lowest dose of fenofibrate without food effect. LCP-AtorFen is designed to be...

  3. Drug

    CVT-6883

    go.drugbank.com/drugs/DB05936
    Experimental

    CVT-6883 is a selective, potent and orally available A2B-adenosine receptor antagonist which CV Therapeutics is investigating for the potential treatment of asthma and other conditions related to inflammation and fibrosis.

  4. Drug

    Thrombopoietin

    go.drugbank.com/drugs/DB06534
    Investigational

  5. Drug

    Estradiol sulfamate

    go.drugbank.com/drugs/DB06597
    Investigational

  6. Drug

    Ilepatril

    go.drugbank.com/drugs/DB06604
    Investigational

  7. Drug

    Otamixaban

    go.drugbank.com/drugs/DB06635
    Investigational

    Otamixaban is a novel direct Factor Xa (FXa) inhibitor. It is currently being developed by the French pharmaceutical company Sanofi-Aventis as a treatment for acute coronary syndrome.

  8. Drug

    Amitifadine

    go.drugbank.com/drugs/DB05964
    Investigational

  9. Drug

    Clazosentan

    go.drugbank.com/drugs/DB06677
    Investigational

  10. Drug

    MC-1

    go.drugbank.com/drugs/DB05315
    Experimental

    Medicure's MC-1 drug is a cardio-protectant, designed to reduce the damage to the heart when arteries are blocked and when they are subsequently reopened after bypass surgery.